 |
|
|
|
|
|
|
|
|
|
|
|
1 to 14 of 14 results |
|
 |
|
|
|
|
|
 |
|
|
|
|
Exley C. on NEWS: Anti-parallel Universe—Rare Amyloid Peptides in Cylinders, Sheets, Neither of these newly identified morphologies are formed in near-physiological media, including... 15 May 2012.
|
|
|
 |
|
|
Exley C. on PAPER: Yan P. et al., 2009, This and other research demonstrates the deposition of Aβ in vivo in an animal model. Do we know... 6 Oct 2009.
|
|
|
|
|
|
Exley C. on PAPER: Kim HS. et al., 2009, Is it only a coincidence that delphinidin (as the 3-glucoside) forms a strong complex with... 14 Jul 2009.
|
|
|
|
|
|
Exley C. on NEWS: Paper Alert: Plasminogen Activator Inhibitor-1 Is Anti-Amyloid Target, I have not yet read the full paper in PNAS (awaiting requested PDF), but it is extremely... 1 Jul 2008.
|
|
|
|
|
|
Exley C. on PAPER: Meyer-Luehmann M. et al., 2008, I agree with Peter Lansbury. This is a beautiful piece of research, though the rapidity with... 11 Feb 2008.
|
|
|
|
|
|
Exley C. on PAPER: Molloy DW. et al., 2007, While there are a number of scientific flaws in both the experimental design and the... 27 Nov 2007.
|
|
|
|
|
|
Exley C. on NEWS: Aβ Star is Born? Memory Loss in APP Mice Blamed on Oligomer, The paper by Lesne et al. is interesting. It would be more convincing if it had included... 21 Mar 2006.
|
|
|
|
|
|
Exley C. on PAPER: Collingwood JF. et al., 2005, One could argue that the dismetabolism of iron, whether throughout the whole body or only in the... 6 Mar 2006.
|
|
|
|
|
|
Exley C. on NEWS: IDE—Levels Up, But Activity Down, in Amyloid-Burdened Vasculature, We already know that another candidate enzyme for the in vivo degradation of Aβ plasmin is... 29 Oct 2004.
|
|
|
|
|
|
Exley C. on NEWS: Coping with Copper—Minute Amount of Metal Plagues Rabbit Brain, The PNAS paper is a follow-up of a similar study published in JAD (Vol 4, 523)in which a... 3 Sep 2003.
|
|
|
|
|
|
Exley C. on LIVE DISCUSSION: β Amyloid Degradation: The Forgotten Half of Alzheimer's Disease, The comment posted by Professor Saido concerning the degradation
of Aβ by proteases,... 11 Sep 2002.
|
|
|
|
|
|
Exley C. on LIVE DISCUSSION: β Amyloid Degradation: The Forgotten Half of Alzheimer's Disease, The authors might like to note our recent research on Aβ
degradation by... 2 Sep 2002.
|
|
|
|
|
|
Exley C. on NEWS: Notch Pathway Implicated in Multiple Sclerosis, The two recent papers published in Science showing an apparent connection between A beta and tau... 29 Jun 2002.
|
|
|
|
|
|
Exley C. on NEWS: Fog Beginning to Clear on Aβ-Degrading Enzymes?, This news report does not mention that the serine protease at the centre of the... 16 Nov 2001.
|
|
|
|
|
|
|
1 to 14 of 14 results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Should the FDA be allowed to use data from overseas clinical trials? |
|
|
|
|
|
|
|
|
|
|
|
Absolutely, we are running out of viable subjects in the U.S. |
|
|
|
|
|
|
 9 |
|
|
|
|
|
|
|
|
|
|
|
Yes, so long as the data is reliable |
|
|
|
|
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
No, the trials are not as rigorous |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
No, the data should be repeated in the U.S. |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
No, the drug sponsors are just trying to cut corners |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Responses: 51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Archived Polls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home
See our latest Webinar: 
